Rhumbline Advisers Adma Biologics, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 615,198 shares of ADMA stock, worth $10.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
615,198
Previous 310,539
98.11%
Holding current value
$10.9 Million
Previous $3.47 Million
254.28%
% of portfolio
0.01%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$330 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$321 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$230 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$224 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$152 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.48B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...